James Godfrey

1.4k total citations
32 papers, 728 citations indexed

About

James Godfrey is a scholar working on Pathology and Forensic Medicine, Oncology and Immunology. According to data from OpenAlex, James Godfrey has authored 32 papers receiving a total of 728 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pathology and Forensic Medicine, 19 papers in Oncology and 12 papers in Immunology. Recurrent topics in James Godfrey's work include Lymphoma Diagnosis and Treatment (21 papers), CAR-T cell therapy research (12 papers) and Immune Cell Function and Interaction (11 papers). James Godfrey is often cited by papers focused on Lymphoma Diagnosis and Treatment (21 papers), CAR-T cell therapy research (12 papers) and Immune Cell Function and Interaction (11 papers). James Godfrey collaborates with scholars based in United States, Canada and United Kingdom. James Godfrey's co-authors include Justin Kline, Stephen M. Ansell, Don M. Benson, Emily Curran, Sonali M. Smith, Brendan W. MacNabb, Jovian Yu, Girish Venkataraman, Robbert M. Spaapen and Douglas E. Kline and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Immunity.

In The Last Decade

James Godfrey

30 papers receiving 725 citations

Peers

James Godfrey

ONCOL

IMMUN

PFM

HEMAT

Jacoba J. Out‐Luiting Netherlands

Brandon Ballard United States

Anna Kozłowska Poland

Alexander Dohnal Austria

Claudia Haftmann Germany

Jérôme Mastio United States

Kawaljit Kaur United States

Matthias Lüftl Germany

Fei Kuang China

Jayeeta Giri United States

Jacoba J. Out‐Luiting Netherlands

James Godfrey

197 ×0.5

ONCOL

348 ×1.1

IMMUN

261 ×1.0

PFM

228 ×1.6

18 ×0.2

HEMAT

Citations per year, relative to James Godfrey James Godfrey (= 1×) peers Jacoba J. Out‐Luiting

Countries citing papers authored by James Godfrey

Since Specialization

Citations

This map shows the geographic impact of James Godfrey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Godfrey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Godfrey more than expected).

Fields of papers citing papers by James Godfrey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Godfrey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Godfrey. The network helps show where James Godfrey may publish in the future.

Co-authorship network of co-authors of James Godfrey

This figure shows the co-authorship network connecting the top 25 collaborators of James Godfrey. A scholar is included among the top collaborators of James Godfrey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Godfrey. James Godfrey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xiao, Annie, Lu Chen, Matthew Mei, et al.. (2025). Real-world infectious complications of CD3/CD20 bispecific antibodies in relapsed/refractory non-Hodgkin lymphoma. Leukemia & lymphoma. 66(12). 2260–2268.

Cahill, Kirk E., James Godfrey, Chadi Nabhan, et al.. (2025). A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL. Blood Advances. 9(21). 5665–5675.

Chen, Xiufen, Jovian Yu, Girish Venkataraman, et al.. (2024). T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses. Cancer Immunology Research. 12(3). 296–307. 1 indexed citations

Cooper, Alan, Girish Venkataraman, Joo Y. Song, et al.. (2023). CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Brutonʼs Tyrosine Kinase Inhibition. Journal of Clinical Oncology. 42(4). 467–480. 10 indexed citations

Ong, Shin Yeu, Matthew Mei, Leslie Popplewell, et al.. (2023). Bendamustine lymphodepletion is a well‐tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B‐cell lymphoma. American Journal of Hematology. 98(11). 1751–1761. 17 indexed citations

Godfrey, James, Xiufen Chen, Nicole Sunseri, et al.. (2023). TIGIT is a key inhibitory checkpoint receptor in lymphoma. Journal for ImmunoTherapy of Cancer. 11(6). e006582–e006582. 13 indexed citations

Cooper, Alan, Girish Venkataraman, Joo Y. Song, et al.. (2023). A CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Brutonʼs Tyrosine Kinase Inhibition. Blood. 142(Supplement 1). 851–851. 2 indexed citations

Godfrey, James, Matthew Mei, Lu Chen, et al.. (2023). Results from a phase I trial of pembrolizumab plus vorinostat in relapsed/refractory B-cell non-Hodgkin lymphoma. Haematologica. 109(2). 533–542. 10 indexed citations

Song, Joo Y., Ting-Fang He, Weiwei Zhang, et al.. (2023). Low T-cell proportion in the tumor microenvironment is associated with immune escape and poor survival in diffuse large B-cell lymphoma. Haematologica. 108(8). 2167–2177. 16 indexed citations

10.

MacNabb, Brendan W., Xiufen Chen, James Godfrey, et al.. (2022). Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing. Immunity. 55(6). 982–997.e8. 105 indexed citations

11.

Godfrey, James, Wenjun Kang, Lei Huang, et al.. (2020). Macrophage Activation By Dual PI3K-δ/γ Inhibition Enhances Anti-CD47-Mediated Phagocytosis and Prolongs Survival in DLBCL. Blood. 136(Supplement 1). 40–40. 4 indexed citations

12.

Huson, Heather J., et al.. (2020). A Genetic Investigation of Island Jersey Cattle, the Foundation of the Jersey Breed: Comparing Population Structure and Selection to Guernsey, Holstein, and United States Jersey Cattle. Frontiers in Genetics. 11. 366–366. 24 indexed citations

13.

Slambrouck, Charles Van, Jooryung Huh, Cheolwon Suh, et al.. (2019). Diagnostic utility of STAT6YE361 expression in classical Hodgkin lymphoma and related entities. Modern Pathology. 33(5). 834–845. 19 indexed citations

14.

Godfrey, James, et al.. (2018). An update in treating transformed lymphoma. Best Practice & Research Clinical Haematology. 31(3). 251–261. 13 indexed citations

15.

Kline, Justin, James Godfrey, Girish Venkataraman, et al.. (2018). PD-L1 Gene Alterations Identify a Unique Subset of Diffuse Large B Cell Lymphoma That Harbors a T Cell Inflamed Phenotype. Blood. 132(Supplement 1). 673–673. 2 indexed citations

16.

Curran, Emily, James Godfrey, & Justin Kline. (2017). Mechanisms of Immune Tolerance in Leukemia and Lymphoma. Trends in Immunology. 38(7). 513–525. 73 indexed citations

17.

Godfrey, James, et al.. (2017). PD-1 blockade induces remissions in relapsed classical Hodgkin lymphoma following allogeneic hematopoietic stem cell transplantation. Journal for ImmunoTherapy of Cancer. 5(1). 11–11. 27 indexed citations

18.

Godfrey, James & Don M. Benson. (2012). The role of natural killer cells in immunity against multiple myeloma. Leukemia & lymphoma. 53(9). 1666–1676. 58 indexed citations

19.

Kayser, Brandon D., James Godfrey, Rochelle Cunningham, et al.. (2009). Equal BMD After Daily or Triweekly Exercise in Growing Rats. International Journal of Sports Medicine. 31(1). 44–50. 5 indexed citations

20.

Godfrey, James, et al.. (2009). Interrupted Resistance Training and BMD in Growing Rats. International Journal of Sports Medicine. 30(8). 579–584. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact